Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.
2.

Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse.

Tomita N, Morishita R, Koike H, Hashizume M, Notake M, Fujitani B, Kaneda Y, Horiuchi M, Ogihara T.

Int J Mol Med. 2002 Aug;10(2):137-43.

PMID:
12119548
3.

In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis.

Tomita N, Morishita R, Lan HY, Yamamoto K, Hashizume M, Notake M, Toyosawa K, Fujitani B, Mu W, Nikolic-Paterson DJ, Atkins RC, Kaneda Y, Higaki J, Ogihara T.

J Am Soc Nephrol. 2000 Jul;11(7):1244-52.

4.
5.

Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners.

Negoro T, Murata M, Ueda S, Fujitani B, Ono Y, Kuromiya A, Komiya M, Suzuki K, Matsumoto J.

J Med Chem. 1998 Oct 8;41(21):4118-29.

PMID:
9767647
6.

Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats.

Honda Y, Minato H, Fujitani B, Masuda Y, Hosoki K.

Methods Find Exp Clin Pharmacol. 1997 Dec;19(10):699-706.

PMID:
9542720
9.

Inhibitory effect of monatepil maleate on acyl-CoA:cholesterol acyltransferase activity in the liver of cholesterol-fed Japanese monkeys.

Sumiya T, Ikeno A, Kato H, Fujitani B, Masuda Y, Hosoki K, Miyazaki M.

Am J Hypertens. 1997 Jul;10(7 Pt 1):779-85.

PMID:
9234833
11.

Prevention by the new Ca2+ channel antagonist, AJ-3941, of loss of endothelium-dependent relaxation after subarachnoid hemorrhage in rats.

Minato H, Honda Y, Masuda Y, Fujitani B, Hosoki K.

Eur J Pharmacol. 1996 Nov 21;315(3):297-303.

PMID:
8982668
14.

Novel fluoroprostacyclin analogs with modified cycloalkylenyl chains. Highly potent and orally active anti-anginal agents.

Matsumura Y, Asai T, Shimada T, Nakayama T, Urushihara M, Morizawa Y, Yasuda A, Yamamoto T, Fujitani B, Hosoki K.

Chem Pharm Bull (Tokyo). 1995 Feb;43(2):353-5. Review.

PMID:
7537179
15.

Pharmacologic properties of a novel Ca2+ entry blocker, AJ-2615, in vitro.

Okamura H, Fujitani B, Furukawa K, Une T, Nukuda T, Komiya M, Kurokawa M.

J Cardiovasc Pharmacol. 1993 Dec;22(6):804-9.

PMID:
7509897
16.

Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.

Katsube N, Sakaguchi K, Fujitani B, Aishita H.

Prostaglandins Leukot Essent Fatty Acids. 1993 Oct;49(4):795-804.

PMID:
8259376
18.

Effect of OP-41483.alpha-CD, a prostacyclin analog, on a clamp-induced endothelial injury in rats.

Matsumoto R, Shiroya T, Naka M, Omawari N, Shinomiya K, Fujitani B, Aishita H.

Life Sci. 1993;53(11):893-900.

PMID:
8366756
19.

Inhibitory effect of OP-41483.alpha-CD, a prostacyclin analog, on peripheral vascular lesion models in rats.

Wakitani K, Takakuwa T, Sugioka M, Fujitani B, Aishita H.

Jpn J Pharmacol. 1992 May;59(1):57-63.

21.
23.

General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.

Nakatsuji K, Matsuno Y, Nakamura N, Fujitani B, Ito T, Kadokawa T.

Arzneimittelforschung. 1987 Oct;37(10):1131-6.

PMID:
3435584
25.
26.

Effect of gliclazide on prostaglandin I2 formation in normal and streptozotocin-induced diabetic animals.

Fujitani B, Maeda J, Tsuboi T, Kadokawa T, Shimizu M.

Jpn J Pharmacol. 1983 Oct;33(5):965-70.

27.

[Enhancement of platelet function in cholesterol-fed guinea-pigs].

Maeda J, Tsuboi T, Fujitani B, Kadokawa T, Shimizu M.

Nihon Yakurigaku Zasshi. 1982 Aug;80(2):105-11. Japanese.

PMID:
6293944
28.

Effect of gliclazide on prostaglandin and thromboxane synthesis in guinea-pig platelets.

Tsuboi T, Fujitani B, Maeda J, Yoshida K, Shimizu M.

Thromb Res. 1981 Jan 1-15;21(1-2):103-10. No abstract available.

PMID:
7233394
29.

Effect of OP 1206, a prostaglandin E1 derivative, on guinea-pig platelet functions.

Tsuboi T, Fujitani B, Maeda J, Yoshida K, Shimizu M, Kawasaki A, Okegawa T, Tsuboshima M.

Thromb Res. 1980 Dec 1-15;20(5-6):573-80. No abstract available.

PMID:
7233385
30.

Pharmacological evaluation of OP 1206, a prostaglandin E1 derivative, as an antianginal agent.

Tsuboi T, Hatano N, Nakatsuji K, Fujitani B, Yoshida K, Shimizu M, Kawasaki A, Sakata M, Tsuboshima M.

Arch Int Pharmacodyn Ther. 1980 Sep;247(1):89-102.

PMID:
7447563
31.

Pharmacological evaluation of ONO 1206, a prostaglandin E1 derivative, as antianginal agent.

Tsuboi T, Hatano N, Nakatsuji K, Fujitani B, Yoshida K, Shimizu M, Kawasaki A, Sakata M, Tsuboshima M.

Adv Prostaglandin Thromboxane Res. 1980;6:347-9. No abstract available.

PMID:
7386273
32.

Aggregation of gel-filtered guinea-pig platelets by lipoproteins.

Fujitani B, Tsuboi T, Yoshida K, Shimizu M.

Thromb Haemost. 1979 Apr 23;41(2):416-24.

PMID:
224521
33.

[Inhibitory effect of gliclazide on platelet adhesiveness and aggregation in alloxan diabetic rabbits (author's transl)].

Kuwashima J, Tsuboi T, Komiya M, Fujitani B, Nakamura K, Maeda J, Kaneko H, Yoshida K, Shimizu M.

Yakugaku Zasshi. 1979 Jan;99(1):59-64. Japanese. No abstract available.

PMID:
430345
34.

Relationship between cerebral energy failure and free fatty acid accumulation following prolonged brain ischemia.

Kuwashima J, Nakamura K, Fujitani B, Kadokawa T, Yoshida K, Shimizu M.

Jpn J Pharmacol. 1978 Apr;28(2):277-87.

35.

Effect of high cholesterol diet on platelet aggregation in guinea pigs.

Yoshida K, Tsuboi T, Fujitani B, Shuri K, Shimizu M.

J Nutr Sci Vitaminol (Tokyo). 1977;23(2):101-13. No abstract available.

PMID:
195021
36.

Inhibition of human and animal platelet adhesiveness to glass bead columns by adenosine, dipyridamole, chlorpromazine and acetylsalicylic acid.

Fujitani B, Tsuboi T, Takeno K, Yoshida K, Shimizu M.

Thromb Haemost. 1976 Nov 30;36(2):401-10.

PMID:
1036841
37.

Biochemical changes in unilateral brain injury in the rat: A possible role of free fatty acid accumulation.

Kuwashima J, Fujitani B, Nakamura K, Kadokawa T, Yoshida K.

Brain Res. 1976 Jul 16;110(3):547-57.

PMID:
947472
38.

Effect of biotin on biochemical changes following isoproterenol-induced myocardial infarction in rats.

Tsuboi T, Fujitani B, Takeno K, Yoshida K, Shimizu M.

Chem Pharm Bull (Tokyo). 1976 Jun;24(6):1123-7. No abstract available.

PMID:
1021277
39.

Pharmacological studies of 3-[bis(3,3-diphenylpropyl)-amino]-propan-1-ol hydrochloride, (PF-244), a new cerebral vasodilator.

Kadokawa T, Fujitani B, Kuwashima J, Hatano N, Shimizu M.

Arzneimittelforschung. 1975 Apr;25(4):632-8.

PMID:
1174078
40.

[Lipid-lowering effect of D,L-alpha-methyl thyroxine ethyl ester (CG-635) and its influence on basal metabolic rate, heart and thyroid gland].

Kuwashima J, Tsuboi T, Fujitani B, Ishikawa K, Nakamura K.

Yakugaku Zasshi. 1974 Dec;94(12):1541-9. Japanese. No abstract available.

PMID:
4476756
41.

Proceedings: Effects of 3-(bis(3,3-diphenylpropyl)-amino)-propane-l-OL hydrochloride, PF-244, on cerebral hemodynamics--antagonism to vasoconstrictive agents.

Kadokawa T, Fujitani B, Kuwashima J, Yoshida K, Shimizu M.

Jpn J Pharmacol. 1974;24(0):s:67. No abstract available.

PMID:
4545968

Supplemental Content

Loading ...
Support Center